Search
Welcome
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Not a subscriber? Subscribe here
Register Now
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
                       
Careers & Tenders
Newsletters
Subscribe
The Mail & Guardian
      SUBSCRIBE / Support independent journalism                   CAREERS & TENDERS / Visit careers.mg.co.za                   WHATSAPP? / Follow the M&G WhatsApp channel here            
Login / Register

LOGIN

  • News
    • Africa
    • Business
    • Editorial
    • Education
    • Health
    • Motoring
    • National
    • Sci-tech
    • Sport
    • World
  • Thought Leader
  • Politics
  • Green Guardian
  • Friday
  • Features
    • Buthelezi, the King’s Hand
    • Cabinet Report Cards 2023
    • Cabinet Report Cards 2012-2021
    • The Fiscal Cliff
  • Research World
    • Submissions
    • Papers
  • Power of Women 2024
  • Events
    • 200 Young South Africans
    • Greening The Future
    • Power Of Women
      • 2024 Edition
    • Critical Thinking Forum
    • Youth Summit
    • Webinars
  • More..
    • Partners
    • Podcasts
    • Crossword
    • Digital Editions
    • Register
    • WhatsApp Channel
    • Login
    • Lost Password

           

Generic Drugs

New drug policy is patently high risk
Article
/ 30 October 2014

New drug policy is patently high risk

There is widespread support for drastic change to patent laws when it comes to pharmaceuticals, but the results could be disastrous.

By Phillip De Wet and Sarah Wild
No image available
Article
/ 11 October 2013

Brazil’s sick of patent exploitation

The country is fighting the intellectual property laws that hiked up the cost of its HIV programme.

By Mara Kardas-Nelson
No image available
Article
/ 11 September 2013

Battle on the horizon over intellectual property policy draft

Some have lauded the draft policy, saying it could make medication cheaper, but others say it is "unimpressive" and "almost contradictory".

By Mara Kardas-Nelson
A ‘shocking’ disregard for generics
Article
/ 15 March 2013

A ‘shocking’ disregard for generics

Many drugs cost far more in South Africa than in countries with strict patent-vetting processes.

By Mara Kardas-Nelson
No image available
Article
/ 18 March 2012

Cheap generics no panacea for India’s poorest

A ruling this week that allowed an Indian drugmaker to make and sell a cancer drug at a fraction of the price has been hailed as a breakthrough.

By Staff Reporter

MAIL & GUARDIAN

ABOUT

About
Contact
Advertise

SUBSCRIPTIONS

Subscribe
Newsletters

FOLLOW

WhatsApp Channel
Twitter
Facebook
YouTube
Instagram
LinkedIn
TikTok
Threads

FLAGSHIP EVENTS

200 Young South Africans
Power Of Women
Greening The Future

LEGAL & CORRECTIONS

Privacy Policy
Cookie Policy
Ethics & Social Media Policy

RESOURCES

Mail & Guardian Careers
Property for sale


Mail & Guardian

© 2025 The Mail & Guardian. All rights reserved.

  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }